# Anastrozole 1 mg Tablets Under Fed Conditions

> **NCT01183390** · PHASE1 · COMPLETED · sponsor: **Teva Pharmaceuticals USA** · enrollment: 22 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Anastrozole
- **DRUG:** Anastrozole

## Key facts

- **NCT ID:** NCT01183390
- **Lead sponsor:** Teva Pharmaceuticals USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2010-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01183390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01183390, "Anastrozole 1 mg Tablets Under Fed Conditions". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01183390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*